Showing results (301-310 of 439) with videos related to
Sort By:
Pageof 44
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2000
Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73J Goudsmit, N Renwick, N H Dukers, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2001
Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapyE H Gisolf, R M van Praag, S Jurriaans, et al.Journal of Virology|April 1, 1995
Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the childG A Mulder-Kampinga, A Simonon, C L Kuiken, et al.British Medical Journal (Clinical Research Ed.)|September 5, 1987
Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemiaF de Wolf, J Goudsmit, D A Paul, et al.AIDS (London, England)|December 31, 1997
AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversionF de Wolf, I Spijkerman, P T Schellekens, et al.The Journal of Infectious Diseases|January 1, 1992
Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjectsC A Boucher, E O'Sullivan, J W Mulder, et al.Pediatrics|October 1, 1986
Neurologic manifestations of human immunodeficiency virus infection in childrenL G Epstein, L R Sharer, J M Oleske, et al.The Journal of Infectious Diseases|September 18, 1997
High-dose interferon-alpha2a exerts potent activity against human immunodeficiency virus type 1 not associated with antitumor activity in subjects with Kaposi's sarcomaP H Frissen, F de Wolf, P Reiss, et al.Neuroradiology|November 9, 2000
Suprasellar seeding of a benign choroid plexus papilloma of the fourth ventricle with local recurrenceM Irsutti, M Thorn-Kany, P Arrué, et al.AIDS (London, England)|November 8, 2001
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strainsJ Goudsmit, G J Weverling, L van der Hoek, et al.Pageof 44